Lung adenocarcinoma (LAD) has extreme genetic variation among patients. which is currently not well understood. limiting progress in therapy development and research. LAD intrinsic molecular subtypes are a validated stratification of naturally-occurring gene expression patterns and encompass different functional pathways and patient outcomes. https://www.hacklinkci.com/